Ex Parte PORTUGAL et al - Page 4



              Appeal No. 2004-1967                                                                Page 4                
              Application No. 09/027,439                                                                                
                     Claims 47, 48 and 53 are directed to isolated nucleic acid molecules comprising                    
              or consisting of SEQ ID NO: 3, 4, 5 or 6; RNA equivalents of SEQ ID NO: 3, 4, 5 or 6;                     
              and complements of SEQ ID NO: 3, 4, 5 or 6.  Claims 47 and 48 distinguish between                         
              “complementary” molecules “capable of base pairing [with molecules comprising or                          
              consisting of SEQ ID NO: 3, 4, 5 or 6] according to the standard Watson-Crick                             
              complementarity rules” (i.e., A to T or U, and G to C) and “substantially complementary”                  
              molecules “capable of hybridizing” to SEQ ID NO: 3, 4, 5 or 6 under specified                             
              conditions.  Ostensibly, substantially complementary nucleic acids are something other                    
              than completely complementary – mismatches can be tolerated, as long as the                               
              molecule is capable of hybridizing to SEQ ID NO: 3, 4, 5 or 6 under the stated                            
              conditions.  Claims 47, 48 and 53 read as follows:                                                        
                     47. An isolated nucleic acid molecule comprising SEQ ID NO: 3, SEQ ID NO: 4,                       
              SEQ ID NO: 5, or SEQ ID NO: 6,                                                                            
                     or an RNA equivalent thereof,                                                                      
                     or a nucleic acid complementary to said isolated molecule, capable of base-                        
              pairing according to the standard Watson-Crick complementarity rules,                                     
                     or a nucleic acid substantially complementary to said isolated molecule which is                   
              capable of hybridizing to the nucleic acid molecule under the following stringent                         
              conditions:                                                                                               
                     hybridization at 40°-65°C for 14-16 hours in a hybridization solution at pH 7.8,                   
              containing 0.9 M NaCl, 0.12 M Tris-HCl, 6 nM EDTA, 0.1 M sodium phosphate buffer,                         
              0.1% SDS and 0.1% polyvinylpyrrolidone,                                                                   
                     followed by three 15-minute washes at 40°-65°C to remove unbound probes in a                       
              solution at pH 7, containing 0.075 M NaCl, 0.0075 M Na Citrate and 0.1% SDS.                              
                     48. An isolated nucleic acid molecule consisting of SEQ ID NO: 3, SEQ ID NO: 4,                    
              SEQ ID NO: 5, or SEQ ID NO: 6,                                                                            
                     or an RNA equivalent thereof,                                                                      
                     or a nucleic acid complementary to said isolated molecule, capable of base-                        
              pairing according to the standard Watson-Crick complementarity rules,                                     
                     or a nucleic acid substantially complementary to said isolated molecule which is                   
              capable of hybridizing to the nucleic acid molecule under the following stringent                         
              conditions:                                                                                               






Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007